OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIV pre-exposure prophylaxis: scaling up for impact now and in the future
Benjamin R. Bavinton, Andrew E. Grulich
The Lancet Public Health (2021) Vol. 6, Iss. 7, pp. e528-e533
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study
Jean‐Michel Molina, Jade Ghosn, Lambert Assoumou, et al.
The Lancet HIV (2022) Vol. 9, Iss. 8, pp. e554-e562
Closed Access | Times Cited: 88

Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections
Fabian Kong, Chris Kenyon, Magnus Unemo
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 7, pp. 1561-1568
Open Access | Times Cited: 43

Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
Connie Celum, Beatriz Grinsztejn, Kenneth Ngure
Journal of the International AIDS Society (2023) Vol. 26, Iss. S2
Open Access | Times Cited: 23

HIV Pre-Exposure Prophylaxis Uptake Among High-Risk Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis
Henry Nagai, Augustine Ankomah, Kamil Fuseini, et al.
AIDS Patient Care and STDs (2024) Vol. 38, Iss. 2, pp. 70-81
Closed Access | Times Cited: 10

Centring the health of women across the HIV research continuum
Elizabeth Barr, Leslie J Marshall, Lauren F. Collins, et al.
The Lancet HIV (2024) Vol. 11, Iss. 3, pp. e186-e194
Open Access | Times Cited: 9

Lenacapavir to prevent HIV infection: current prices versus estimated costs of production
Andrew Hill, Jacob Levi, Cassandra Fairhead, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access | Times Cited: 8

Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments
Luh Putu Lila Wulandari, Shi Yi He, Christopher K. Fairley, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101507-101507
Open Access | Times Cited: 30

Pre-exposure prophylaxis use, HIV knowledge, and internalized homonegativity among men who have sex with men in Brazil: A cross-sectional study
Kevin J. Blair, Thiago S. Torres, Brenda Hoagland, et al.
The Lancet Regional Health - Americas (2021) Vol. 6, pp. 100152-100152
Open Access | Times Cited: 34

Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials
István Szondy, Fanni Adél Meznerics, Kende Lőrincz, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107186-107186
Open Access | Times Cited: 5

What will it take to expand the pre-exposure prophylaxis to prevent new HIV infections in India?
Aditya H. Gaur, Natella Rakhmanina
The Indian Journal of Medical Research (2025) Vol. 160, pp. 527-529
Open Access

Considerations for capsid-targeting antiretrovirals in pre-exposure prophylaxis
William M. McFadden, Mia Færch, Karen A. Kirby, et al.
Trends in Molecular Medicine (2025)
Closed Access

Knowledge and perception of HIV pre-exposure prophylaxis among healthcare workers
Paula Knoch Mendonça Gil, Danilo dos Santos Conrado, Ana Isabel do Nascimento, et al.
AIDS Care (2025), pp. 1-10
Closed Access

“Any time because I am ready”: Willingness to use long-acting injectable HIV PrEP among female barmaids in Dar es Salaam, Tanzania
Winfrida Onesmo Akyoo, Idda H. Mosha, Albrecht Jahn, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access

Scaling up preexposure prophylaxis to maximize HIV prevention impact
Andrew E. Grulich, Benjamin R. Bavinton
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 4, pp. 173-178
Closed Access | Times Cited: 19

The Unseen Impact of Affordability: Copayment Sensitivity for Long-Acting PrEP Among MSM in Europe
Haoyi Wang, Johann Kolstee, Hanne M. L. Zimmermann, et al.
(2025)
Closed Access

HIV pre-exposure prophylaxis (PrEP) use among PrEP-eligible men who have sex with men: a systematic review and meta-analysis
Yuyan Zhao, Huishan Li, Yi‐Ting Huang, et al.
International Journal of Infectious Diseases (2025), pp. 107874-107874
Open Access

Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention
Antoine Khati, Michael D. Miller, Ran Xu, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209693-209693
Closed Access

Persistent disparities in COVID-19-associated impacts on HIV prevention and care among a global sample of sexual and gender minority individuals
Glenn‐Milo Santos, Chenglin Hong, Natalie Wilson, et al.
Global Public Health (2022) Vol. 17, Iss. 6, pp. 827-842
Open Access | Times Cited: 18

Examining provincial PrEP coverage and characterizing PrEP awareness and use among gay, bisexual and other men who have sex with men in Vancouver, Toronto and Montreal, 2017–2020
Jordan M. Sang, Katherine McAllister, Lu Wang, et al.
Journal of the International AIDS Society (2022) Vol. 25, Iss. 10
Open Access | Times Cited: 17

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future
Deniz Gökengin, Dominik Bursa, Agata Skrzat‐Klapaczyńska, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 122-122
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top